Toll Biotech Co. Ltd. (Beijing)
3 clinical trials · Sponsor
◉ Watch Toll Biotech Co. Ltd. (Beijing)
| Record | Firm | Date |
|---|---|---|
| A Phase II Study of TollB-001 Tablets in Systemic Sclerosis (NCT07745725) | Toll Biotech Co. Ltd. (Beijing) | 2026-08-01 |
| Safety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis (NCT07408024) | Toll Biotech Co. Ltd. (Beijing) | 2025-09-10 |
| A Study of Single and Multiple Oral Doses of TollB-001 (NCT06103773) | Toll Biotech Co. Ltd. (Beijing) | 2023-09-28 |
Track Toll Biotech Co. Ltd. (Beijing) automatically
Every clearance here is in the API, with alerts when new ones post.